Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic Sites-Reference-Cited by-同舟云学术

Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic Sites

Published:2023-08 Issue: Volume: Page:
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Tappero Stefano^ORCID,Piccinelli Mattia Luca^ORCID,Incesu Reha-Baris,Cano Garcia Cristina^ORCID,Barletta Francesco,Morra Simone^ORCID,Scheipner Lukas^ORCID,Baudo Andrea,Tian Zhe,Parodi Stefano^ORCID,Dell'Oglio Paolo,de Cobelli Ottavio,Graefen Markus,Chun Felix K.H.,Briganti Alberto,Longo Nicola,Ahyai Sascha,Carmignani Luca,Saad Fred,Shariat Shahrokh F.,Suardi Nazareno,Borghesi Marco,Terrone Carlo^ORCID,Karakiewicz Pierre I.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference14 articles.

1. Prognosis of patients with prostate carcinoma presenting as nonregional lymph node metastases;Furuya;Urol Int,1998

2. Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer;Ost;Prostate,2014

3. Impact of the site of metastases on survival in patients with metastatic prostate cancer;Gandaglia;Eur Urol,2015

4. Location of metastases in contemporary prostate cancer patients affects cancer-specific mortality;Mazzone;Clin Genitourin Cancer,2018

5. Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer;Halabi;J Clin Oncol,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival of Metastatic Urothelial Carcinoma of Urinary Bladder According to Number and Location of Visceral Metastases;Clinical Genitourinary Cancer;2024-10

2. Survival Patterns Based on First-site–specific Visceral Metastatic Prostate Cancer: Are Outcomes of Visceral Metastases the Same?;European Urology Open Science;2024-08

3. Survival of patients with lymph node versus bone versus visceral metastases according to CHAARTED/LATITUDE criteria in the era of intensified combination therapies for metastatic hormone‐sensitive prostate cancer;The Prostate;2024-07-10

4. Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer?;Cancers;2024-06-26